Advertisement

Cluster and Facial Headache

  • Robert G. KanieckiEmail author
Chapter

Abstract

  • Trigeminal autonomic cephalalgias (TACs) are primary headache disorders characterized by unilateral head pain of varying duration associated with ipsilateral cranial autonomic features.

  • TACs differ primarily in episode duration, frequency, and periodicity.

  • Cluster headache and short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) are more common among men, while chronic paroxysmal hemicrania (CPH) and hemicrania continua (HC) among women.

  • The duration of headache attacks (15–180 min) helps differentiate cluster headache from the other TACs and also from migraine headache (4–72 h).

  • SUNCT is best differentiated from trigeminal neuralgia (TN) by location of pain (V1 versus V2–V3 for TN) and the prominent ipsilateral autonomic features (rare in TN).

  • Cerebral blood flow studies reveal hyperactivation of the hypothalamus ipsilateral to the pain in cluster headache, contralateral to the pain in CPH and HC, and bilateral in SUNCT.

  • Oxygen therapy and subcutaneous sumatriptan are the agents of choice for the treatment of acute attacks of cluster headache.

  • Prevention of cluster headache is most frequently accomplished with short-term corticosteroids and long-term verapamil. Electrocardiographic monitoring is necessary for those patients with cluster headache requiring verapamil doses greater than 240 mg.

  • Paroxysmal hemicrania and hemicrania continua are prevented absolutely by therapeutic doses of indomethacin. Co-administration of a proton pump inhibitor may improve the tolerability of long-term indomethacin dosing.

  • SUNCT is the most brief, least common, and most refractory TAC. Lamotrigine is the treatment of choice.

References

  1. 1.
    Burns B, Watkins L, Goadsby P. Treatment of intractable cluster headache by occipital nerve stimulation in 14 patients. Neurology. 2009;72:341–5.CrossRefPubMedGoogle Scholar
  2. 2.
    Cittadini E, Goadsby P. Update on hemicrania continua. Curr Pain Headache Rep. 2011;15:51–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Cohen A. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing. Cephalalgia. 2007;27:824–32.CrossRefPubMedGoogle Scholar
  4. 4.
    Cohen A, Burns B, Goadsby P. High-flow oxygen for treatment of cluster headache. JAMA. 2009;302:2451–7.CrossRefPubMedGoogle Scholar
  5. 5.
    Francis G, Becker W, Pringsheim T. Acute and preventive pharmacologic treatment of cluster headache. Neurology. 2010;75:463–73.CrossRefPubMedGoogle Scholar
  6. 6.
    Goadsby P, Lipton R. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic features, including new cases. Brain. 1997;120:193–209.CrossRefPubMedGoogle Scholar
  7. 7.
    Headache Classification Committee of the International Headache Society. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.CrossRefGoogle Scholar
  8. 8.
    Hong RD. The surgical treatment of headache. Headache. 2014;54:409–29.CrossRefPubMedGoogle Scholar
  9. 9.
    Iacovelli E, Coppola G, Tinelli E, et al. Neuroimaging in cluster headache and other trigeminal autonomic cephalalgias. J Headache Pain. 2012;13:11–20.CrossRefPubMedGoogle Scholar
  10. 10.
    Lademann V, Jansen J-P, Evers S, et al. Evaluation of guideline-adherent treatment in cluster headache. Cephalalgia 2016;36:760–64.Google Scholar
  11. 11.
    Leone M, D’Amico D, Frediani F, et al. Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo. Neurology. 2000;54:1382–5.CrossRefPubMedGoogle Scholar
  12. 12.
    May A. Diagnosis and clinical features of trigemino-autonomic headaches. Headache. 2013;53:1470–8.CrossRefPubMedGoogle Scholar
  13. 13.
    May A, Leone M, Afra J, et al. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol. 2006;13:1066–77.CrossRefPubMedGoogle Scholar
  14. 14.
    Pareja J, Sjaastad O. SUNCT syndrome. A clinical review. Headache. 1997;47:195–202.CrossRefGoogle Scholar
  15. 15.
    Pareja J, Alvarez M. The usual treatment of trigeminal autonomic cephalalgias. Headache. 2013;53:1401–14.CrossRefPubMedGoogle Scholar
  16. 16.
    Pedersen J, Barloese M, Jensen R. Neurostimulation in cluster headache: a review of current progress. Cephalalgia. 2013;33:1179–93.CrossRefPubMedGoogle Scholar
  17. 17.
    Peres M, Stiles M, Siow H, et al. Greater occipital nerve block for cluster headache. Cephalalgia. 2002;22:520–2.CrossRefPubMedGoogle Scholar
  18. 18.
    Tfelt-Hansen P, Tfelt-Hansen J. Verapamil for cluster headache: clinical pharmacology and possible mode of action. Headache. 2009;49:117–25.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of NeurologyUniversity of PittsburghPittsburghUSA

Personalised recommendations